Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
(Q79345406)
scientific article published on 09 November 2006
scientific article published on 09 November 2006
Language:
Current Data About
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
other details
description | scientific article published on 09 November 2006 |
External Links
(P356) |
10.1038/SJ.LEU.2404442
|
(P698) |
17096017
|
(P6179) |
1030328715
|
(P8608) |
release_vy55t2xuzzdi3ks7xqfr4ze2sm
|